As a trusted partner in the small-molecule CDMO space, we continue to strengthen our core business while proactively expanding into new frontiers—including oligonucleotide therapeutics—to build a more diversified service capability matrix.

Safety is the cornerstone of development and the most solemn commitment we make to every employee. This June, Lianhe Aigen launched an in-depth series of activities for Workplace Safety Month under the theme “Everyone Speaks Safety, Everyone Knows Emergency Response — Identify and Address Risks and Hazards.”

CPHI China 2026 was a wonderful gathering, and more importantly, it marks the beginning of lasting collaborations. We look forward to transforming the consensus reached at the exhibition into tangible cooperation outcomes.

Lianhe Aigen has always believed that the ultimate purpose of dedicated R&D and rigorous manufacturing is to protect lives and benefit humanity. And this commitment to caring for people extends from our production lines to society at large—this is not only our bounden duty, but also our enduring promise.

"Benchmark Leadership, Collective Progress" is not just a learning campaign but also a hands-on practice of management philosophy. Moving forward, the workshop will continue to be guided by benchmarks, driving all employees to channel their incremental improvements into a powerful force supporting the company's high-quality development.

This equipment upgrade not only marks a significant step forward in fire safety management but also serves as a key driver in transforming emergency response capabilities—shifting from experience-driven to technology-driven approaches, and from passive reaction to proactive prevention. Together, these advancements build a more solid defense line